Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 141.42%283.04K | 136.12%297.87K | -33.68%109.53K | -43.33%598.68K | -45.49%190.13K | -54.20%117.24K | -61.36%126.15K | 31.94%165.16K | 9.61%1.06M | 45.66%348.79K |
| Selling and administrative expenses | 122.82%238.28K | 138.49%279.45K | -34.67%100.89K | -44.24%544.56K | -49.69%166.01K | -52.89%106.94K | -61.76%117.18K | 36.33%154.43K | 11.67%976.63K | 55.15%329.97K |
| -General and administrative expense | 122.82%238.28K | 138.49%279.45K | -34.67%100.89K | -44.24%544.56K | -49.69%166.01K | -52.89%106.94K | -61.76%117.18K | 36.33%154.43K | 11.67%976.63K | 55.15%329.97K |
| Depreciation amortization depletion | 3.38%4.19K | -6.57%3.84K | -7.04%3.86K | 0.00%16.49K | 0.75%4.18K | -2.88%4.05K | 0.83%4.11K | 1.34%4.15K | -44.57%16.49K | -3.93%4.15K |
| -Depreciation and amortization | 3.38%4.19K | -6.57%3.84K | -7.04%3.86K | 0.00%16.49K | 0.75%4.18K | -2.88%4.05K | 0.83%4.11K | 1.34%4.15K | -44.57%16.49K | -3.93%4.15K |
| Other operating expenses | 549.01%40.58K | 199.61%14.58K | -27.16%4.79K | -40.61%37.63K | 35.98%19.94K | -74.83%6.25K | -69.70%4.87K | -15.75%6.58K | 6.48%63.36K | -34.73%14.66K |
| Operating profit | -141.42%-283.04K | -136.12%-297.87K | 33.68%-109.53K | 43.33%-598.68K | 45.49%-190.13K | 54.20%-117.24K | 61.36%-126.15K | -31.94%-165.16K | -9.61%-1.06M | -45.66%-348.79K |
| Net non-operating interest income (expenses) | -77.46%-464.63K | 77.50%-52.23K | -29.75%-228.05K | 0.63%-901.39K | -1.34%-231.66K | -18.26%-261.82K | 4.46%-232.16K | 17.93%-175.76K | 45.43%-907.12K | -160.94%-228.59K |
| Non-operating interest expense | 75.72%452.79K | -97.80%5.01K | 29.96%223.59K | 6.87%877.17K | 10.24%219.81K | 29.50%257.68K | 7.63%227.63K | -18.42%172.05K | -50.23%820.76K | 152.68%199.39K |
| Total other finance cost | 185.53%11.84K | 943.79%47.22K | 19.97%4.46K | -71.94%24.23K | -59.44%11.84K | -81.49%4.15K | -85.64%4.52K | 14.24%3.72K | 552.55%86.35K | 761.55%29.2K |
| Other net income (expenses) | 61.51%-73.68K | -117.20%-310.37K | 171.79%775.03K | 112.37%90.06K | -123.99%-443.39K | -130.53%-191.43K | 154.25%1.8M | -977.75%-1.08M | -314.78%-728.07K | 552.17%1.85M |
| Gain on sale of security | 226.59%255.93K | -126.11%-288.52K | 188.02%601.32K | 6.62%768.88K | -59.41%548.98K | -135.79%-202.16K | 176.62%1.11M | -377.30%-683.13K | 23.04%721.12K | 201.41%1.35M |
| Special income (charges) | -1,563.82%-330.59K | -103.13%-21.96K | 150.36%168.42K | 59.24%-571.03K | -272.77%-961.78K | -52.08%22.58K | 137.29%702.63K | -178.17%-334.46K | -598.14%-1.4M | 398.79%556.67K |
| -Less:Other special charges | 1,563.82%330.59K | 103.13%21.96K | -150.36%-168.42K | -59.24%571.03K | 272.77%961.78K | 52.08%-22.58K | -137.29%-702.63K | 178.17%334.46K | 598.14%1.4M | -398.79%-556.67K |
| Other non-operating income (expenses) | 108.29%983 | 103.09%103 | 108.54%5.3K | -122.87%-107.79K | 49.52%-30.59K | -179.21%-11.86K | -991.98%-3.34K | -1,892.54%-62.01K | -4.12%-48.36K | -387.77%-60.59K |
| Income before tax | -43.97%-821.35K | -145.67%-660.47K | 130.80%437.45K | -13.79%-3.06M | -298.10%-2.52M | -481.32%-570.5K | 137.12%1.45M | -556.64%-1.42M | -17.69%-2.69M | 203.30%1.27M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -43.97%-821.35K | -145.67%-660.47K | 130.80%437.45K | -13.79%-3.06M | -298.10%-2.52M | -481.32%-570.5K | 137.12%1.45M | -556.64%-1.42M | -17.69%-2.69M | 203.30%1.27M |
| Net income continuous operations | -43.97%-821.35K | -145.67%-660.47K | 130.80%437.45K | -13.79%-3.06M | -298.10%-2.52M | -481.32%-570.5K | 137.12%1.45M | -556.64%-1.42M | -17.69%-2.69M | 203.30%1.27M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -43.97%-821.35K | -145.67%-660.47K | 130.80%437.45K | -13.79%-3.06M | -298.10%-2.52M | -481.32%-570.5K | 137.12%1.45M | -556.64%-1.42M | -17.69%-2.69M | 203.30%1.27M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -43.97%-821.35K | -145.67%-660.47K | 130.80%437.45K | -13.79%-3.06M | -298.10%-2.52M | -481.32%-570.5K | 137.12%1.45M | -556.64%-1.42M | -17.69%-2.69M | 203.30%1.27M |
| Diluted earnings per share | 0 | 0 | 0 | 0.00%-0.01 | -0.01 | 0 | 0 | 0 | 0.00%-0.01 | 0 |
| Basic earnings per share | 0 | 0 | 0 | 0.00%-0.01 | -0.01 | 0 | 0 | 0 | 0.00%-0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.